Ayurvedic therapy in the management of chronic obstructive pulmonary disease with Brihatkataphaladi Vati, Vasadi Kashaya, and polyherbal nebulisation.

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
INTERVENTION: CONDITION: Health Condition 1: J449‐ Chronic obstructive pulmonary disease, unspecified PRIMARY OUTCOME: Change in COPD(CA22) symptom severity from baseline to end of treatment, assessed using a validated tool such as COPD Assessment Test (CAT) score (mean changes from baseline to end of treatment).Timepoint: 90 days SECONDARY OUTCOME: 1. Improvement in FEV1 ; 2. Improvement in FEV1/FVC ratio ; 3.Frequency and severity of exacerbations during the study period (Frequency of hospitalisations from baseline to end of treatment). ; 4.Reduction in use of rescue medication (e.g., short‐acting bronchodilators) (Frequency of rescue medicines consumed from baseline to end of treatment). ; 5.Improvement in Ayurvedic symptomatology (e.g., Shwasakrichhrata, Kasa, Ghurghuraka) using a structured Ayurvedic symptom scoring scale (mean changes from baseline to end of treatment). ; 6.Safety and tolerability assessed through clinical monitoring and laboratory investigations (e.g., CBC, LFT, KFT) (mean changes from baseline to end of treatment). ; Timepoint: 90 days INCLUSION CRITERIA: 1.Clinically stable (no acute exacerbation in last 4 weeks) cases diagnosed with Chronic Obstructive Pulmonary Disease as per GOLD guidelines based on FEV1/FVC below 0.70 and Tamaka Shwasa as per Ayurvedic texts 2.Participants aged from 40 to 80 years irrespective of gender. 3.Participants getting conventional treatment as per allopathic standards. 4.GOLD grade I II and III. 5.Participants willing for the trial and ready to give written consent
Epistemonikos ID: c027e1c8b919c8a1af795d8d7ad5756cb947af86
First added on: Aug 08, 2026